Felux Jasmin, Sturm Ekkehard, Busch Andreas, Zerabruck Emanuel, Graepler Florian, Stüker Dietmar, Manger Andreas, Kirschner Hans-Joachim, Blumenstock Gunnar, Malek Nisar P, Goetz Martin
Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.
Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Tübingen, Tübingen, Germany.
United European Gastroenterol J. 2017 Nov;5(7):1024-1029. doi: 10.1177/2050640616687868. Epub 2017 Jan 11.
Indications for endoscopic retrograde cholangiopancreatography (ERCP) in children differ from adults. Paucity of data and concerns about potential lower effectiveness and more side effects limit its use even in high volume centers. We retrospectively analyzed indications, success rates, limitations, and side effects of ERCPs in children <18 years.
From January 2012 to March 2015, 54 ERCPs were performed in 31 children (median age 11 (0-17) years; median weight 22 (3.3-142.7) kg) with suspected choledocholithiasis ( = 13 interventions in 9 patients), post-transplantation anastomotic stenosis (10/4), malignancy (10/5), chronic pancreatitis (7/1), biliary atresia (6/6), anomaly (2/2), leak (4/3), or primary sclerosing cholangitis (PSC) (2/1). All patients were followed up as inpatients.
Thirty-six therapeutic and 18 diagnostic procedures were performed by adult ERCP expert endoscopists. Successful intervention was achieved in 90.7% of cases. Failed cannulation ( = 4) was associated with lower body weight ( = 0.023). In children younger than 1 year, ERCP was significantly more often diagnostic than in patients >1 year ( < 0.001). In three of six infants with suspected atresia, surgical exploration was avoided. Five complications were recorded (9.3%), and included four episodes of mild pancreatitis (7.4% post-ERCP pancreatitis (PEP) rate) and one cholangitis in PSC. A trend towards a protective effect of pancreatic stents on PEP was observed. All complications were managed conservatively. No complications were attributed to mechanical stress on the gastrointestinal tract.
ERCP in newborns, infants, and adolescents can be safely performed with high technical and clinical success. Endoscopists must be aware of differing spectrum of pediatric diseases. Failed cannulation was associated with lower body weight of young children. Complications were similar to rates reported in adults.
儿童内镜逆行胰胆管造影术(ERCP)的适应证与成人不同。数据匮乏以及对潜在较低有效性和更多副作用的担忧限制了其在甚至是高容量中心的使用。我们回顾性分析了18岁以下儿童ERCP的适应证、成功率、局限性和副作用。
2012年1月至2015年3月,对31例儿童(中位年龄11(0 - 17)岁;中位体重22(3.3 - 142.7)kg)进行了54次ERCP,这些儿童疑似胆总管结石(9例患者中有13次干预)、移植后吻合口狭窄(10/4)、恶性肿瘤(10/5)、慢性胰腺炎(7/1)、胆道闭锁(6/6)、畸形(2/2)、渗漏(4/3)或原发性硬化性胆管炎(PSC)(2/1)。所有患者均作为住院患者进行随访。
由成人ERCP专家内镜医师进行了36次治疗性和18次诊断性操作。90.7%的病例成功进行了干预。插管失败(=4)与较低体重相关(=0.023)。1岁以下儿童中,ERCP诊断性操作的比例显著高于1岁以上患者(<0.001)。6例疑似闭锁的婴儿中有3例避免了手术探查。记录到5例并发症(9.3%),包括4例轻度胰腺炎(ERCP后胰腺炎(PEP)发生率为7.4%)和1例PSC患者发生的胆管炎。观察到胰腺支架对PEP有保护作用的趋势。所有并发症均经保守治疗。没有并发症归因于胃肠道的机械性应激。
新生儿、婴儿和青少年的ERCP可以安全地进行,技术和临床成功率高。内镜医师必须了解儿科疾病的不同范围。插管失败与幼儿较低体重相关。并发症发生率与成人报告的相似。